TP53 and breast cancer: Besides, it was indicated that miR‐193a‐3p is able to decrease the expression level of some targets such as ING‐5, HOXC9, and PSEN‐1 in chemoresistant bladder cancer cells and the response to the chemotherapy could be improved.15-17 Our study demonstrated that miR-193a-5p could increase the sensitivity of BC cells to paclitaxel and also presented that miR-193a is involved in the management of apoptosis by targeting P53.